Analysis of cells away from the laboratory

Cytomos aims to revolutionise cell analysis by moving key tests out of the laboratory.

Cytomos’ proprietary and patentable technology, which is in early stage development, is low-cost, portable and scalable. It aims to enable non-specialist users to perform quantitative cell analysis for research or clinical diagnostics, in the lab, field, or at the point of care. Its products will get results faster, simplify the logistics of testing and reduce costs.

YEAR OF INVESTMENT
2014
WEBSITE
cytomos.com
OBSERVER
Sarah Hardy